Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/10/2009WO2008135830A8 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
12/10/2009WO2008124814A3 Sublingual formulations of d-cycloserine and methods of using same
12/10/2009WO2008109498A8 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof
12/10/2009WO2007096782A3 Compositions for disorders associated wtth metachromatic cell activation
12/10/2009WO2005075663A3 Nanosized composite material containing a biological compound and process for the preparation
12/10/2009US20090306579 Delivery of corticosteroids through iontophoresis
12/10/2009US20090306371 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
12/10/2009US20090306222 Food supplements and uses thereof
12/10/2009US20090306221 Use for Cannabinoid
12/10/2009US20090306220 Stable organic peroxide compositions
12/10/2009US20090306219 Topical use of plant extract for skin detoxification
12/10/2009US20090306218 Antimicrobial formulations
12/10/2009US20090306216 Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
12/10/2009US20090306215 Deuterium-enriched arformoterol
12/10/2009US20090306214 Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
12/10/2009US20090306213 Process for Synthesis of Glycomimicking Cationic Amphiphiles
12/10/2009US20090306212 Compositions and Methods for Treating Diabetes and Neuropsychological Dysfunction
12/10/2009US20090306211 Peritoneal dialysis fluid
12/10/2009US20090306209 Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same
12/10/2009US20090306208 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria
12/10/2009US20090306207 Treatment of Drug-Resistant Proliferative Disorders
12/10/2009US20090306205 Methoxypolyethylene glycol thioester chelate and uses thereof
12/10/2009US20090306204 Pharmaceutical Composition Comprising Cyclobenzaprine and Aceclofenac in Association
12/10/2009US20090306203 [3-(Hydroxyamino)-cyclopentylsulfanyl]acetic acid mutilin-14-yl ester, used for the treatment of bacterial diseases; antibiotics
12/10/2009US20090306202 9-Fluoro-11-hydroxy-16-methyl-3,17a-dioxo-17-(hydroxymethyl)-D-homoandrosta-1,4-dien-17-yl-(1-adamantyl)carbamate; advantages oversteroids being side effect reduction, efficiency, nontoxic; immunosuppressants; antiinflammatory agents; autoimmune diseases
12/10/2009US20090306201 Selective inhibitors for transferases
12/10/2009US20090306200 Prophylactic or Therapeutic Agent for Nocturnal Conduct Disorder Associated With Dementia
12/10/2009US20090306199 Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts
12/10/2009US20090306198 Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner
12/10/2009US20090306197 Substituted Chromanol Derivatives and Their Use
12/10/2009US20090306196 Imine based liquid crystals for the controlled release of bioactive materials
12/10/2009US20090306195 Fusion Proteins of Mycobacterium Tuberculosis
12/10/2009US20090306194 Novel compositions for the in vivo delivery of rnai agents
12/10/2009US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
12/10/2009US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
12/10/2009US20090306191 Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification
12/10/2009US20090306190 Neuroprotectants
12/10/2009US20090306189 Methods for Controlling Pests Using Rnai
12/10/2009US20090306188 Importation of mitochondrial protein by an enhanced allotopic approach
12/10/2009US20090306187 Modulators of Itch Ubiquitinase Activity
12/10/2009US20090306186 Novel tissue protective erythropoietin receptor (nepor) and methods of use
12/10/2009US20090306185 Nanogenomics for medicine: siRNA engineering
12/10/2009US20090306184 A composition comprising two double stranded nucleic acid molecules ; nucleic acids with a pyrimidine modification
12/10/2009US20090306183 Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
12/10/2009US20090306182 RNA INTERFERENCE MEDIATED INHIBITION OF MAP KINASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/10/2009US20090306181 Compositions and methods for evaluating and treating heart failure
12/10/2009US20090306180 Compounds and methods for modulating expression apob
12/10/2009US20090306179 Compounds and methods for modulating expression of gcgr
12/10/2009US20090306178 Conjugated double strand compositions for use in gene modulation
12/10/2009US20090306176 Use Of Low Doses Of Oligonucleotides Antisense To TGF-Beta, VEGF, Interleukin-10, C-Jun, C-Fos Or Prostaglandin E2 Genes In The Treatment Of Tumors
12/10/2009US20090306175 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
12/10/2009US20090306174 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
12/10/2009US20090306173 Crystalline forms of atorvastatin magnesium
12/10/2009US20090306172 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
12/10/2009US20090306171 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors
12/10/2009US20090306170 Synthesis of tegaserod or a salt thereof
12/10/2009US20090306169 Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
12/10/2009US20090306168 SirT Inhibitors That Bind to NAD
12/10/2009US20090306167 Pharmaceutical Compositions for Intranasal Administration Comprising a Melatonin Receptor Agonist, Uses Thereof
12/10/2009US20090306165 Dipeptide compounds containing d-histidine
12/10/2009US20090306164 Methods for Treating Papilloma Virus Infection
12/10/2009US20090306163 Topical compositions comprising imidazolidinedione analogs and their use to treat or prevent the appearance of skin wrinkling
12/10/2009US20090306161 Methods of treating alpha adrenergic mediated conditions
12/10/2009US20090306160 Methods for improving drug disposition
12/10/2009US20090306159 Inhibition of Intermediate-Conductance Calcium Activated Potassium Channels in the Treatment and/or Prevention of Atherosclerosis
12/10/2009US20090306158 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators 286
12/10/2009US20090306157 Antiseptic Alginate Preparation
12/10/2009US20090306156 Phosphodiesterase 4 inhibitors
12/10/2009US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009US20090306153 Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases
12/10/2009US20090306152 Cooling cosmetic or dermatological preparations comprising (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide in combination with menthoxypropanediol
12/10/2009US20090306151 Pharmaceutical preparation containing an angiotensin II receptor antagonist and a calcium channel blocker
12/10/2009US20090306150 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/10/2009US20090306149 Use of biarylcarboxamies in the treatment of hedgehog pathway-related disorders
12/10/2009US20090306148 Use of Thiazolidinediones for the Partial Inhibition of Androgen Binding to Aromatase
12/10/2009US20090306145 Pyridylisoxazole Derivatives
12/10/2009US20090306144 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
12/10/2009US20090306143 vanilloid receptor antagonists such as N-(1,2-Dimethyl-1H-benzimidazol-5-yl)-5-fluoro-1-(4,6-dimethylpyridin-2-yl)-1H-indole-2-carboxamide, used for the treatment of inflammation, psoriasis, pruritus, herpes, shingles, multiple sclerosis, metabolic, gastrointestinal and respiratory system disorders
12/10/2009US20090306142 METHODS TO CONTROL QoI-RESISTANT FUNGAL PATHOGENS
12/10/2009US20090306141 Novel Compounds
12/10/2009US20090306140 3 or 4-Substituted Piperidine Compounds
12/10/2009US20090306139 Heteroaryl-substituted piperidines
12/10/2009US20090306138 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents
12/10/2009US20090306137 Treatment for depressive disorders
12/10/2009US20090306136 Benzenesulfonamide Compounds and the Use Thereof
12/10/2009US20090306135 Stable amorphous fexofenadine hydrochloride
12/10/2009US20090306134 Muscarinic receptor antagonists
12/10/2009US20090306133 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
12/10/2009US20090306132 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases
12/10/2009US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof
12/10/2009US20090306130 Novel tetrahydro-isoquinolines
12/10/2009US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
12/10/2009US20090306128 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009US20090306126 Indole Derivatives
12/10/2009US20090306125 Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
12/10/2009US20090306124 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
12/10/2009US20090306123 Bicyclononene derivaties
12/10/2009US20090306122 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially of tyrosine and raf kinases
12/10/2009US20090306121 Aza-beta-carbolines and methods of using same
1 ... 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 ... 7860